![Helén Tuvesson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Helén Tuvesson
Directeur Général chez
ACTIVE BIOTECH AB
Profil
Helén Tuvesson is currently President & Chief Executive Officer at Active Biotech AB since 2017, Chairman at Active Security Trading AB, Independent Director at Mendus AB since 2020, and Director at Actinova AB. Formerly, Dr. Tuvesson was Principal at Pharmacia AB. Education includes a doctorate from the University of Lund.
Postes actifs de Helén Tuvesson
| Sociétés | Poste | Début |
|---|---|---|
| ACTIVE BIOTECH AB | Directeur Général | 01/07/2017 |
| MENDUS AB | Directeur/Membre du Conseil | 01/01/2020 |
Active Security Trading AB | Président | - |
Actinova AB | Directeur/Membre du Conseil | - |
Anciens postes connus de Helén Tuvesson
| Sociétés | Poste | Fin |
|---|---|---|
Pharmacia AB
 Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Corporate Officer/Principal | - |
Formation de Helén Tuvesson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
26
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Active Biotech AB
 Active Biotech AB BiotechnologyHealth Technology Develops drugs for cancer, neurodegenerative and inflammatory diseases | Health Technology |
Pharmacia AB
Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mendus AB
 Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
Active Security Trading AB | |
Actinova AB |
Choisissez Zonebourse 
